March 31, 2020 / 2:00 AM / 4 months ago

BRIEF-Genscript Biotech Says Unit Sells 19.3 Million Series A Preference Shares For US$150.5 Mln

March 31 (Reuters) - Genscript Biotech Corp:

* UNIT SELLS 19.3 MILLION SERIES A PREFERENCE SHARES FOR US$150.5 MILLION TO JOHNSON & JOHNSON INNOVATION, LAV BIOSCIENCES FUND & OTHERS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below